| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/02/2009 | CA2700164A1 Phage .phi.mru polynucleotides and polypeptides and uses thereof |
| 04/02/2009 | CA2700162A1 Cell-permeabilising peptides and polypeptides for microbial cells |
| 04/02/2009 | CA2700129A1 Vaccines and vaccine components for inhibition of microbial cells |
| 04/02/2009 | CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same |
| 04/01/2009 | EP2042869A2 High affinity TCR proteins and methods |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042600A1 A public and immunogenic CD4+ T Cell epitope of the hiv tat protein and its applications |
| 04/01/2009 | EP2042598A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 04/01/2009 | EP2042597A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042594A1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 04/01/2009 | EP2042592A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042516A1 Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same |
| 04/01/2009 | EP2042515A1 Ligand binding domains of nuclear receptors in controllable form and methods involving the same |
| 04/01/2009 | EP2042514A1 Maintenance of hair growth and treatment of hair-loss |
| 04/01/2009 | EP2042513A1 Galectin 9-polymer conjugate |
| 04/01/2009 | EP2042512A2 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 04/01/2009 | EP2042511A1 Method for pre-treatment of serum for analysis of sugar chain |
| 04/01/2009 | EP2042509A1 Modulators of the function of FAS receptors and other proteins |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042192A2 Tolerogenic fragments of natural allergens |
| 04/01/2009 | EP2041321A2 Viral inhibitory nucleotide sequences and vaccines |
| 04/01/2009 | EP2041287A1 Methods for effectively coexpressing il-12 and il-23 |
| 04/01/2009 | EP2041283A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 04/01/2009 | EP2041181A1 Specific protease inhibitors and their use in cancer therapy |
| 04/01/2009 | EP2041179A2 Antigenic surface structure of sperm cells associated with the y chromosome |
| 04/01/2009 | EP2041176A1 Antibody molecules for human il-17 |
| 04/01/2009 | EP2041174A2 Novel peptides that promote lipid efflux |
| 04/01/2009 | EP2041173A2 Peptides with anti-proliferative activity |
| 04/01/2009 | EP2041172A1 Cellular pyrogenic test using toll-like receptor |
| 04/01/2009 | EP2041171A2 Epitope-tag for surface-expressed proteins and uses thereof |
| 04/01/2009 | EP2041170A1 Method for producing insulin analogs having a dibasic b chain terminus |
| 04/01/2009 | EP2041169A1 Amidated glargine insulin |
| 04/01/2009 | EP2041168A2 Novel analogs of vasoactive intestinal peptide |
| 04/01/2009 | EP2041167A1 Derivatisation of granulocyte colony-stimulating factor |
| 04/01/2009 | EP2041166A1 Process for globular adiponectin production |
| 04/01/2009 | EP2041165A2 Novel applications for staphylococcus aureus sbi protein |
| 04/01/2009 | EP2041164A2 Improved inorganic phosphate assays |
| 04/01/2009 | EP2041163A2 A family of pesticidal proteins and methods for their use |
| 04/01/2009 | EP2041162A2 Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity |
| 04/01/2009 | EP2041161A1 Chiral compounds substituted with phosphonate ester or phosphonic acid |
| 04/01/2009 | EP2040757A2 New protein conjugates and methods for their preparation |
| 04/01/2009 | EP2040743A2 Vaccines for malaria |
| 04/01/2009 | EP2040740A2 Compositions and methods for the delivery of nitric oxide |
| 04/01/2009 | EP2040723A1 Method and use of lactic acid bacteria with increased acid tolerance |
| 04/01/2009 | EP1939216A4 Immunomodulating composition |
| 04/01/2009 | EP1871792A4 Human protooncogene trg and protein encoded therein |
| 04/01/2009 | EP1629098B1 Complement inhibitors from ticks |
| 04/01/2009 | EP1585984B1 Diagnostic methods for protein profiling |
| 04/01/2009 | EP1561116B9 Scd40l and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1472375B1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 04/01/2009 | EP1456239B1 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 04/01/2009 | EP1455592B1 Enhanced oil seed protein recovery |
| 04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1323353B1 Fractionated soybean protein and process for producing the same |
| 04/01/2009 | EP1292613B9 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level |
| 04/01/2009 | EP1153139B1 Polymorphic markers of the lsr gene |
| 04/01/2009 | EP1137666B9 Glp-1 analogues |
| 04/01/2009 | EP1131087B2 Alleviatation of prostate cancer symptoms |
| 04/01/2009 | EP1119623B1 Mage-a3 peptides presented by hla class ii molecules |
| 04/01/2009 | EP0970207B1 Heregulin variants |
| 04/01/2009 | EP0888386B2 Stable, virus-safe factor VIII-complex concentrate |
| 04/01/2009 | CN101400793A Novel cancer-associated antigen |
| 04/01/2009 | CN101400700A Composition and method to increase mammalian sperm function |
| 04/01/2009 | CN101400699A Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions |
| 04/01/2009 | CN101400698A Amylin derivatives |
| 04/01/2009 | CN101400697A Prevention/treatment of ichthyosis vulgaris, atopy and other disorders |
| 04/01/2009 | CN101400696A Protein having ice nucleating activity |
| 04/01/2009 | CN101400695A Protein having ice nucleating activity |
| 04/01/2009 | CN101400694A Genes useful for the industrial production of citric acid |
| 04/01/2009 | CN101400693A Peptides of regulatory or accessory proteins of HIV, compositions and the utilization thereof |
| 04/01/2009 | CN101400692A Potent compstatin analogs |
| 04/01/2009 | CN101400366A Hepatitis c virus non structural fusion protein |
| 04/01/2009 | CN101397574A Flavivirus NS1 subunit vaccine |
| 04/01/2009 | CN101397565A Rice high affinity nitrate transport protein gene OsNAR2.1 |
| 04/01/2009 | CN101397564A Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/01/2009 | CN101397563A T2r taste receptors and genes encoding same |
| 04/01/2009 | CN101397560A Method for producing human tumor necrosis factor-alpha |
| 04/01/2009 | CN101397341A Lipase inhibitor from natto, preparation method and use thereof |
| 04/01/2009 | CN101397340A Basic orange artificial antigen synthesis and antibody preparation method |
| 04/01/2009 | CN101397339A Method for removing/inactivating virus in glucoprotein |
| 04/01/2009 | CN101397338A Detection method for protein activity of fish growth hormone |
| 04/01/2009 | CN101397337A Neuroregulation protein mutant and uses thereof |
| 04/01/2009 | CN101397336A Antigenic Neisserial peptides |
| 04/01/2009 | CN101397335A Particles of HCV envelope proteins: use for vaccination |
| 04/01/2009 | CN101397334A Anti-human cytomegalovirus gBn1 antibody, preparation method and special antigen |
| 04/01/2009 | CN101397332A Functional peptide section of epididymis protease inhibitors and multiple antigenic peptide constructed thereby |
| 04/01/2009 | CN100473725C Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor |
| 04/01/2009 | CN100473724C Novel VIP3 toxins and methods of use |
| 04/01/2009 | CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response |
| 04/01/2009 | CN100473663C Heterologous expression of neisserial proteins |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 04/01/2009 | CN100473659C Hop mosaic virus gene and method for detecting hop mosaic virus |
| 04/01/2009 | CN100473641C Monoclonal antibody for ketamine detection and immune detection board |
| 04/01/2009 | CN100473586C Lock for a flat and low pourer |
| 04/01/2009 | CN100473417C Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 03/31/2009 | US7511198 Transformed maize plant comprising in its genome at least one stably incorporated heterologous nucleic acid molecule comprising a DNA insert; modulating phytate and increasing phosphorus levels; nutritional feeds and foods; gene expression inhibition |